|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
SCIDIR_ocn989820458 |
| 003 |
OCoLC |
| 005 |
20231120112234.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
170427s2017 ne ob 001 0 eng d |
| 040 |
|
|
|a NLE
|b eng
|e rda
|e pn
|c NLE
|d OCLCF
|d OCLCQ
|d YDX
|d N$T
|d IDEBK
|d EBLCP
|d OPELS
|d MERER
|d OTZ
|d D6H
|d UAB
|d UPM
|d STF
|d OCLCO
|d U3W
|d OCLCQ
|d AU@
|d OCLCO
|d LVT
|d LQU
|d OCLCQ
|d UKMGB
|d OCLCQ
|d OCLCO
|d S2H
|d OCLCO
|d OCL
|d OCLCQ
|d SFB
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBB780898
|2 bnb
|
| 016 |
7 |
|
|a 018339625
|2 Uk
|
| 019 |
|
|
|a 988278360
|a 988383493
|a 993946373
|a 1105186753
|a 1105573973
|a 1229838404
|
| 020 |
|
|
|a 9780128097182
|q (ePub ebook)
|
| 020 |
|
|
|a 0128097183
|q (ePub ebook)
|
| 020 |
|
|
|z 9780128097175
|q (pbk.)
|
| 020 |
|
|
|z 0128097175
|
| 035 |
|
|
|a (OCoLC)989820458
|z (OCoLC)988278360
|z (OCoLC)988383493
|z (OCoLC)993946373
|z (OCoLC)1105186753
|z (OCoLC)1105573973
|z (OCoLC)1229838404
|
| 050 |
|
4 |
|a RS201.N35
|b N36 2017
|
| 060 |
|
4 |
|a QV 785
|
| 072 |
|
7 |
|a HEA
|x 012000
|2 bisacsh
|
| 072 |
|
7 |
|a HEA
|x 020000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 004000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 101000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 109000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 029000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 040000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 092000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.6
|2 23
|
| 245 |
0 |
0 |
|a Nanotechnology-based approaches for targeting and delivery of drugs and genes /
|c edited by Vijay Mishra, Prashant Kesharwani, Mohd Cairul Iqbal Mohd Amin, Arun Iyer.
|
| 264 |
|
1 |
|a Amsterdam :
|b Academic Press,
|c 2017.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Section 1: Introduction and Issues in Nanomedicine 1. Nanotechnology in development of nanomedicines 2. Concept of enhanced permeability and retention (EPR) effect for drug targeting 3. Non-EPR effect for Targeting 4. Translational Medicine 5. Quality-by-design approach in development of nanocarriers Section 2: Current Technologies in Nanomedicine 6. Liposomes in targeting and delivery of drugs 7. Surfactant-based nanocarriers in targeting and delivery of drugs 8. Polymeric micelle in targeting and delivery of drugs 9. Polymeric nanoparticles in targeting and delivery of drugs 10. Solid Lipid Nanoparticles in targeting and delivery of drugs 11. Dendrimers in targeting and delivery of drugs 12. Carbon nanotubes in targeting and delivery of drugs 13. Quantum dots in targeting and delivery of drugs 14. Biomaterials in peptides and protein delivery Section 3 -- Future Developments and Challenges in Nanomedicine 15. Biopharmaceutical Aspects of Nanomaterials 16. Toxicity Issues of Nanocarriers.
|
| 588 |
0 |
|
|a CIP data; item not viewed.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Drug delivery systems.
|
| 650 |
|
0 |
|a Gene therapy.
|
| 650 |
|
0 |
|a Nanomedicine.
|
| 650 |
|
0 |
|a Drug carriers (Pharmacy)
|
| 650 |
|
2 |
|a Drug Carriers
|0 (DNLM)D004337
|
| 650 |
|
2 |
|a Drug Delivery Systems
|0 (DNLM)D016503
|
| 650 |
|
2 |
|a Genetic Therapy
|0 (DNLM)D015316
|
| 650 |
|
2 |
|a Nanomedicine
|0 (DNLM)D050997
|
| 650 |
|
6 |
|a Syst�emes d'administration de m�edicaments.
|0 (CaQQLa)000260397
|
| 650 |
|
6 |
|a Th�erapie g�enique.
|0 (CaQQLa)201-0193146
|
| 650 |
|
6 |
|a Vecteurs de m�edicaments.
|0 (CaQQLa)000260399
|
| 650 |
|
6 |
|a Nanom�edecine.
|0 (CaQQLa)201-0448752
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Holism.
|2 bisacsh
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Reference.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Alternative Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Atlases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Essays.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Family & General Practice.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Holistic Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Osteopathy.
|2 bisacsh
|
| 650 |
|
7 |
|a Drug carriers (Pharmacy)
|2 fast
|0 (OCoLC)fst00898662
|
| 650 |
|
7 |
|a Drug delivery systems
|2 fast
|0 (OCoLC)fst00898667
|
| 650 |
|
7 |
|a Gene therapy
|2 fast
|0 (OCoLC)fst00939638
|
| 650 |
|
7 |
|a Nanomedicine
|2 fast
|0 (OCoLC)fst01744350
|
| 700 |
1 |
|
|a Mishra, Vijay,
|e editor.
|
| 700 |
1 |
|
|a Kesharwani, Prashant,
|e editor.
|
| 700 |
0 |
|
|a Mohd. Cairul Iqbal bin Mohd. Amin,
|e editor.
|
| 700 |
1 |
|
|a Iyer, Arun,
|e editor.
|
| 776 |
0 |
8 |
|i Print version :
|z 9780128097175
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128097175
|z Texto completo
|
